Abstract：Objective: To explore the influence factors of vascular disease in type 2 diabetes mellitus, and provide the basis for early effective prevention and treatment of diabetic foot and heart and cerebrovascular diseases. Methods: 187 patients with type 2 diabetes who were treated in Department of endocrinology of Chengde College Affiliated Hospital from October 2015 to April -2017 were selected as subjects. According to the level of hyperhomocysteinemia (Hcy), the patients were divided into high Hcy group and normal Hcy group. The effects of low density lipoprotein cholesterol (LDL-C), homocysteine (Hcy), triglyceride (TG) and glycosylated hemoglobin (HbAlc) and other risk factors on diabetic peripheral vascular disease in two groups were compared. Results: When high Hcy was combined with high SBP, high LDL-C, high TG and high HbAlc, the risk of diabetic peripheral vascular disease was significantly higher than that of single risk factor (P<0.05). Conclusion: The level of plasma homocysteine is related to the severity of peripheral vascular disease in type 2 diabetes, and plasma high Hcy concentration combined with metabolic syndrome is more prone to diabetic peripheral vascular disease.
刘畅, 王英南, 李桂芳, 晏飞, 宋娜, 金凤表, 高宇. 高同型半胱氨酸血症合并代谢综合征对2型糖尿病周围血管病变的影响[J]. 河北医学, 2018, 24(4): 630-632.
LIU Chang, WANG Yingnan, LI Guifang, et al. Effect of Hyperhomocysteine Combined with Metabolic Syndrome on the Peripheral Vascular Lesions of Type 2 Diabetes Mellitus. HeBei Med, 2018, 24(4): 630-632.
[1] 李中南,方朝晖,李远思,等.高血压对老年糖尿病患者下肢血管病变的影响[J].中国临床保健杂志,2006,9(4):319~320. [2] 金亚丽,袁永红,全菊花,等.血同型半胱氨酸对糖尿病肾病和2型糖尿病合并颈动脉斑块的影响的临床研究[J].糖尿病新世界,2016,19(12):119~121. [3] Zhang D, Zhou Y, Han L, et al. The effect of MTHFR C677T polymorphism on type 2 diabetes mellitus with vascular complications in Chinese Han population: a meta-analysis[J]. Endocrine Journal, 2014, 61(7):717. [4] Bjornshave A, Hermansen K. Effects of dairy protein and fat on the metabolic syndrome and type 2 diabetes[J]. Review of Diabetic Studies Rds, 2014, 11(2):153. [5] 陆菊明.二甲双胍类降糖药对大血管病变保护作用的基础与临床研究[J].中国卒中杂志,2007,2(7):591~593.
2018, Vol. 24 
冀公网安备13080202000677号